Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.07%GBPCHF+1.01%AUDUSD-1.00%USDCHF+0.92%GBPCAD+0.78%USDCAD+0.71%GBPNZD+0.71%GBPJPY+0.69%NZDUSD-0.65%EURGBP-0.64%USDJPY+0.61%USDTHB+0.58%EURUSD-0.57%PLNJPY+0.51%EURAUD+0.45%NOKJPY+0.44%SGDJPY+0.42%GBPTRY+0.41%AUDJPY-0.41%AUDNZD-0.35%EURCHF+0.34%GBPHKD+0.32%AUDCAD-0.31%USDTRY+0.29%GBPMXN-0.28%CHFJPY-0.27%NZDCHF+0.27%AUDSGD+0.23%AUDNOK+0.22%CADCHF+0.21%USDILS+0.16%AUDDKK+0.15%EURCAD+0.14%NZDMXN-0.12%AUDCHF-0.11%EURNZD+0.10%USDSGD+0.10%CADJPY-0.09%USDCNH-0.09%USDNOK+0.08%GBPUSD+0.07%EURCNH+0.07%EURSGD+0.07%EURNOK+0.06%NZDCAD+0.06%CHFSGD+0.06%USDZAR+0.05%EURHKD-0.04%CHFNOK+0.04%EURJPY+0.04%USDCOP-0.04%GBPSGD+0.03%USDHKD+0.03%EURCZK+0.03%NZDJPY-0.03%USDDKK+0.02%CHFSEK-0.02%EURZAR+0.02%USDMXN+0.02%NZDSGD-0.02%GBPZAR-0.02%USDSEK+0.02%USDPLN+0.02%EURPLN-0.01%EURSEK-0.01%EURDKK0.00%USOIL-1.34%GAGUSD+1.21%XAGUSD+1.21%UKOIL-1.12%XNGUSD-0.61%HG1-0.59%S1-0.58%W1-0.48%XAUUSD+0.45%GAUUSD+0.45%COTTON-0.43%C1-0.42%BTCUSD+0.16%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.13%ZECUSDT+0.71%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+1.27%XLMUSD+2.73%BCHUSDT+0.01%UNIUSD+0.27%LTCUSD+0.07%HBARUSDT+2.58%SUIUSD+1.91%TONUSD+15.77%TAOUSDT+1.73%AAVEUSD+0.14%DOTUSDT+4.80%ICPUSDT-1.20%ONDOUSDT+1.10%WLDUSDT+9.89%ARBUSDT+0.82%JUPUSDT+0.10%ATOMUSDT+3.19%INJUSDT-2.02%STXUSDT+22.12%FETUSDT+4.67%SEIUSDT+1.01%PYTHUSDT-1.28%TIAUSDT+3.33%IMXUSDT+3.40%GRTUSDT+1.69%OPUSDT+0.54%WIFUSDT+4.29%IOTAUSDT+7.21%POLUSDT-3.71%AXSUSDT+1.63%FARTCOINUSDT+0.58%EOSUSDT+4.34%DYDXUSDT+5.38%GALAUSDT+4.75%ORDIUSDT+3.11%NOTUSDT+3.60%RONINUSDT+3.21%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.07%GBPCHF+1.01%AUDUSD-1.00%USDCHF+0.92%GBPCAD+0.78%USDCAD+0.71%GBPNZD+0.71%GBPJPY+0.69%NZDUSD-0.65%EURGBP-0.64%USDJPY+0.61%USDTHB+0.58%EURUSD-0.57%PLNJPY+0.51%EURAUD+0.45%NOKJPY+0.44%SGDJPY+0.42%GBPTRY+0.41%AUDJPY-0.41%AUDNZD-0.35%EURCHF+0.34%GBPHKD+0.32%AUDCAD-0.31%USDTRY+0.29%GBPMXN-0.28%CHFJPY-0.27%NZDCHF+0.27%AUDSGD+0.23%AUDNOK+0.22%CADCHF+0.21%USDILS+0.16%AUDDKK+0.15%EURCAD+0.14%NZDMXN-0.12%AUDCHF-0.11%EURNZD+0.10%USDSGD+0.10%CADJPY-0.09%USDCNH-0.09%USDNOK+0.08%GBPUSD+0.07%EURCNH+0.07%EURSGD+0.07%EURNOK+0.06%NZDCAD+0.06%CHFSGD+0.06%USDZAR+0.05%EURHKD-0.04%CHFNOK+0.04%EURJPY+0.04%USDCOP-0.04%GBPSGD+0.03%USDHKD+0.03%EURCZK+0.03%NZDJPY-0.03%USDDKK+0.02%CHFSEK-0.02%EURZAR+0.02%USDMXN+0.02%NZDSGD-0.02%GBPZAR-0.02%USDSEK+0.02%USDPLN+0.02%EURPLN-0.01%EURSEK-0.01%EURDKK0.00%USOIL-1.34%GAGUSD+1.21%XAGUSD+1.21%UKOIL-1.12%XNGUSD-0.61%HG1-0.59%S1-0.58%W1-0.48%XAUUSD+0.45%GAUUSD+0.45%COTTON-0.43%C1-0.42%BTCUSD+0.16%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.13%ZECUSDT+0.71%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+1.27%XLMUSD+2.73%BCHUSDT+0.01%UNIUSD+0.27%LTCUSD+0.07%HBARUSDT+2.58%SUIUSD+1.91%TONUSD+15.77%TAOUSDT+1.73%AAVEUSD+0.14%DOTUSDT+4.80%ICPUSDT-1.20%ONDOUSDT+1.10%WLDUSDT+9.89%ARBUSDT+0.82%JUPUSDT+0.10%ATOMUSDT+3.19%INJUSDT-2.02%STXUSDT+22.12%FETUSDT+4.67%SEIUSDT+1.01%PYTHUSDT-1.28%TIAUSDT+3.33%IMXUSDT+3.40%GRTUSDT+1.69%OPUSDT+0.54%WIFUSDT+4.29%IOTAUSDT+7.21%POLUSDT-3.71%AXSUSDT+1.63%FARTCOINUSDT+0.58%EOSUSDT+4.34%DYDXUSDT+5.38%GALAUSDT+4.75%ORDIUSDT+3.11%NOTUSDT+3.60%RONINUSDT+3.21%
XP

Xenon Pharmaceuticals Inc. (XENE)

NASDAQ • Healthcare

$37.19
-$0.06 (-0.2%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$37.38
Day Range$36.71 - $37.53
Avg. Volume (3M)2.4M
Market Cap$3.5B
52 Week Range
$36.07$72.66
Next EarningsIn 32 daysNov 2, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$409.1M
EPS (TTM)
-$4.74
ROA (TTM)
-31.58%
Current Ratio
21.02

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-9.2%Q1 2026-$1.31
0.0%Q2 2026-$1.17
+2.6%Q3 2026-$1.11
Next

Nov 2

in 32 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +2.6%

Xenon Pharmaceuticals topped the EPS estimate in the second fiscal quarter of 2026, reported on August 6, based on preliminary results, with EPS of $-1.11 against a $-1.14 estimate, +2.6%. The company said net income was a loss of about $110.7 million, down 30.7% from a loss of $84.7 million a year ago, while EPS improved to $-1.11 from $-1.07 a year earlier, a 3.7% decline. Operating income came in at about negative $123.2 million, and operating cash flow was negative $95.4 million. Consensus for the next period calls for EPS of $-1.17 on revenue of $1.3 million.

View full earnings history

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. develops ion channel-targeted medicines for neurological disorders as a clinical-stage biotechnology company listed on the NASDAQ Global Market under ticker XENE. Founded in 1996 and based in Burnaby, British Columbia, Xenon centers its pipeline on experimental therapies for epilepsy, developmental and epileptic encephalopathies, and pain.

Name
Xenon Pharmaceuticals Inc.
CEO
Ian C. Mortimer
Website
www.xenon-pharma.com
Industry
Healthcare
Year Founded
1996
Employees
364

Today's Snapshot

AI-generated

The day ended with XENE slightly lower at 37.19, while its sector was weaker. Shares changed hands at about half of its usual level.

Trading Volume

Below 10d avg (4.3M)

2.4M

vs S&P 500 Today

Moderate Underperformance

-0.35%

Updated: September 30, 2026 at 20:26 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
XENE is well below its moving averages across horizons, reflecting a clear downtrend with strong directional force as ADX is high. Momentum measures are deeply negative and MACD shows substantial bearish divergence, even though oscillators register extreme lows that signal oversold conditions. Volatility is elevated and on-balance volume is negative, consistent with distribution during the decline, and the pivot sits close to the market as a short-term reference. Taken together, price, momentum and volume point to pronounced downside pressure. Technical takeaway: Strong sell bias dominates the technical picture.
All signals
  • EMA (5 indicators)$40.89 - $55.44
    Sell
  • RSI (14)18.62
    Buy
  • Stochastic %K (14, 3, 3)4.11
    Buy
  • MACD Level (12, 26)-6.63
    Sell

Peers & Related Assets

APGEApogee Therapeutics, Inc.
$135.07-0.0%
CGONCG Oncology Inc.
$70.89+0.5%
SRRKScholar Rock Holding Corporation
$48.32+1.2%
TVTXTravere Therapeutics, Inc.
$58.88-1.9%
CELCCelcuity Inc.
$79.52+2.8%
RAREUltragenyx Pharmaceutical Inc.
$15.03-1.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.